Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: In vitro and in vivo production of biologically active interleukin-12

Human Gene Therapy

Volumn 7, Issue 3, 1996, Pages 333-342

  Bramson, J ^a   Hitt, M ^a   Gallichan, W S ^a   Rosenthal, K L ^a   Gauldie, J ^a   Graham, F L ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; INTERLEUKIN 12; LYMPHOKINE; PHYTOHEMAGGLUTININ;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADENOVIRUS 5; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CELL LINE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; IMMUNOMODULATION; INFECTION; LYMPHOBLAST; MOUSE; NATURAL KILLER CELL; NONHUMAN; SPLEEN CELL; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; HUMAN ADENOVIRUS TYPE 5; MURINAE;

EID: 0030057511     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.3-333     Document Type: Article

References (38)

1. ADDISON, C.L., BRACIAK, T., RALSTON, R., MULLER, W.J., GAULDIE, J., and GRAHAM, F.L. (1995a). Intra-tumoral injection of an adenovirus expressing interleukin-2 induces regression and immunity in a murine breast cancer model. Proc. Natl. Acad. Sci. USA 92, 8522-8526.
2. ADDISON, C.L., GAULDIE, J., MULLER, W.J., and GRAHAM, F.L. (1995b). An adenovirus vector expressing interleukin-4 modulates tumorigenicity and induces tumor regression in a murine breast cancer model. Int. J. Oncol. 7, 1253-1260.
3. BETT, A.J., HADDARA, W., PREVEC, L., and GRAHAM, F.L. (1994). An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA 91, 8802-8806.
4. BIRNBOIM, H.C., and DOLY, J. (1979). A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7, 1513-1523.
5. BRACIAK, T.A., MITTAL, S.K., GRAHAM, F.L., RICHARDS, C.D., and GAULDIE, J. (1993). Construction of recombinant human type 5 adenoviruses expressing rodent IL-6 genes: An approach to investigate in vivo cytokine function. J. Immunol. 151, 5145-5153.
6. BRUNDA, M.J., LUISTRO, L., WARRIER, R.R., WRIGHT, R.B., HUBBARD, B.R., MURPHY, M., WOLF, S.F., and GATELY, M.K. (1993). Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178, 1223-1230.
7. CHEHIMI, J., STARR, S.E., FRANK, I., REGHARAJU, M., JACKSON, S.J., LLANES, C., KOBAYASHI, M., PERUSSIA, B., YOUNG, D., NICKBARG, E., WOLF, S.F., and TRINCHIERI, G. (1992). Natural Killer (NK) Cell Stimulatory Factor increases the cytotoxic activity of NK cells from both healthy donors and Human Immunodeficiency Virus-infected patients. J. Exp. Med. 175, 789-796.
8. CHEHIMI, J., STARR, S.E., FRANK, I., D'ANDREA, A., MA, X., MACGREGOR, R.R., SENNELIER, J., and TRINCHIERI, G. (1994). Impaired interleukin 12 production in Human Immunodeficiency Virus-infected patients. J. Exp. Med. 179, 1361-1366.
9. CLERICI, M., LUCEY, D.R., BERZOFSKY, J.A., PINTO, L.A., WYNN, T.A., BLATT, S.P., DOLAN, M.J., HENDRIX, C.W., WOLF, S.F., and SHEARER, G.M. (1993). Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 262, 1721-1724.
10. GATELY, M.K., WARRIER, R.R., HONASOGE, S., CARVAJAL, D.M., FAHERTY, D.A., CONNAUGHTON, S.E., ANDERSON, T.D., SARMIENTO, U., HUBBARD, B.R., and MURPHY, M. (1994). Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo. Int. Immunol. 6, 157-167.
11. GRAHAM, F.L., SMILEY, J., RUSSELL, W.C., and NAIRN, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-72.
12. GUBLER, U., CHUA, A.O., SCHOENHAUT, D.S., DWYER, C.M., McCOMAS, W., MOTYKA, R., NABAVI, N., WOLITZKY, A.G., QUINN, P.M., FAMILLETTI, P.C., and GATELY, M.K. (1991). Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA 88, 4143-4147.
13. GUY, C.T., CARDIFF, R.D., and MULLER, W.J. (1992). Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol. Cell Biol. 12, 954-961.
14. HEINZEL, F.P., SHOENHAUT, D.S., RERKO, R.M., ROSSER, L.E. and GATELY, M.K. (1993). Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177, 1505-1509.
15. HITT, M., BETT, A.J., PREVEC, L., and GRAHAM, F.L. (1994). Construction and propagation of human adenovirus vectors. In Cell Biology: A Laboratory Handbook. J.E. Celis, ed. (Academic Press, San Diego) pp. 479-490.
16. HITT, M., BETT, A.J., ADDISON, C.L., PREVEC, L., and GRAHAM, F.L. (1995). Techniques for human adenovirus vector construction and characterization. In Methods in Molecular Genetics. Vol. 7. K.W. Adolph, ed. (Academic Press, Orlando, FL) pp. 13-30.
17. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547-549.
18. JOHNSON, D.C., GHOSH-CHOUDHURY, G., SMILEY, J.R., FALLIS, L., and GRAHAM, F.L. (1988). Abundant expression of herpes simplex virus glycoprotein gB using an adenovirus vector. Virology 164, 1-14.
19. MANETTI, R., PARRONCHI, P., GIUDIZI, M.G., PICCINNI, M.-P., MAGGI, E., TRINCHIERI, G., and ROMAGNANI, S. (1993). Natural killer cells stimulatory factor (interleukin 12 [IL12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177, 1199-1204.
20. MITTAL, S.K., McDERMOTT, M.R., JOHNSON, D.C., PREVEC, L., and GRAHAM, F.L. (1993). Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res. 28, 67-90.
21. MITTAL, S.K., BETT, A.J., PREVEC, L., and GRAHAM, F.L. (1995). Foreign gene expression by human adenovirus type 5 based vectors studied using firefly luciferase and bacterial beta-galactosidase genes as reporters. Virology 210, 226-230.
22. MORSY, M.A., ALFORD, E.L., BETT, A., GRAHAM, F.L., and CASKEY, C.T. (1993). Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes. J. Clin. Invest. 92, 1580-1586.
23. MURPHY, E.E., TERRES, G., MACATONIA, S.E., HSIEH, C.-S., MATTSON, J., LANIER, L., WYSOCKA, M., TRINCHIERI, G., MURPHY, K., and O'GARRA, A. (1994). B7 and interleukin 12 cooperate for proliferation and interferon y production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 180, 223-231.
24. MURRAY, H.W., and HARIPRASHAD, J. (1995). Interleukin 12 is effective treatment for an established systemic intracellular infection: Experimental visceral Leishmaniasis. J. Exp. Med. 181, 387-391.
25. NABORS, G.S., AFONSO, L.C.C., FARRELL, J.P., and SCOTT, P. (1995). Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam. Proc. Natl. Acad. Sci. USA 92, 3142-3146.
26. NASTALA, C.L., EDINGTON, H.D., McKINNERY, T.G., TAHARA, H., NALESNIK, M.A., BRUNDA, M.J., GATELY, M.K., WOLF, S.F., SCHREIBER, R.D., STORKUS, W.J., and LOTZE, M.T. (1994). Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol. 153, 1697-17067
27. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd ed. (Cold Spring Harbor Press, Cold Spring Harbor, NY) pp. 1.21-1.84.
28. SARMIENTO, U.M., RILEY, J.H., KNAACK, P.A., LIPMAN, J.M., BECKER, J.M., GATELY, M.K., CHIZZONITE, R., and ANDERSON, T.D. (1994). Biological effects of recombinant human interleukin-12 in Squirrel monkeys (Sciureus saimiri). Lab. Invest. 71, 862-873.
29. SCHOENHAUT, D.S., CHUA, A.O., WOLITZKY, A.G., QUINN, P.M., DWYER, C.M., McCOMAS, W., FAMILLETTI, P.C., GATELY, M.K., and GUBLER, U. (1992). Cloning and expression of murine IL-12. J. Immunol. 148, 3433-3440.
30. STERN, A.S., PODLASKI, F.J., HULMES, J.D., PAN, Y-C. E., QUINN, P.M., WOLITZKY, A.G., FAMILLETTI, P.C., STERMLO, D.L. TRUITT, T., CHIZZONITE, R., and GATELY, M.K. (1990). Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 87, 6808-6812.
31. SYPEK, J.P., CHUNG, C.L., MAYOR, S.E.H., SUBRAMANYAM, J.M., GOLDMAN, S.J., SIEBURTH, D.S., WOLF, S.F., and SCHAUB, R.G. (1993). Resolution of cutaneous Leishmaniasis: Interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177, 1797-1802.
32. TAHARA, H., ZEH III, H.J., STORKUS, W.J., PAPPO, I., WATKINS, S.C., GUBLER, U., WOLF, S.F., ROBBINS, P.D., and LOTZE, M.T. (1994). Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res. 54, 182-189.
33. TRINCHIERI, G. (1994). Interleukin 12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84, 4008-4027.
34. TRIPATHY, S.K., GOLDWASSER, E., LU, M.-M., BARR, E., and LEIDEN, J.M. (1994). Stable delivery of physiological levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc. Natl. Acad. Sci. USA 91, 11557-11561.
35. WOLF, S.F., TEMPLE, P.A., KOBAYASHI, M., YOUNG, D., DICIG, M., LOWE, L., DZIALO, R., FITZ, L., FERENZ, C., HEWICK, R.M., KELLEHER, K., HERRMANN, S.H., CLARK, S.C., AZZONI, L., CHAN, S.H., TRINCHIERI, G., and PERUSSIA, B. (1991). Cloning of cDNA for Natural Killer Cell Stimulatory Factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146, 3074-3081.
36. XING, Z., BRACIAK, T., JORDANA, M., CROITORU, K. GRAHAM, F.L., and GAULDIE, J. (1994). Adenovirus-mediated cytokine gene transfer at tissue sites: Overexpression of IL-6 induces lymphocytic hyperplasia in the lung. J. Immunol. 153, 4059-4069.
37. YANG, Y., NUNES, F.A., BERENCSI, K., Gönczöl, E., Englehardt, J.F., and WILSON, J.M. (1994). Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet. 7, 362-369.
38. ZITVOGEL, L., TAHARA, H., CAI, Q., STORKUS, W.J., MULLER, G., WOLF, S.F., GATELY, M., ROBBINS, P.D., and LOTZE, M.T. (1994). Construction and characterization of retroviral vectors expressing biologically active human interleukin-12. Hum. Gene Ther. 5, 1493-1506.